Therapeutic Implications of Ceritinib in Cholangiocarcinoma beyond ALK Expression and Mutation

Therapeutic Implications of Ceritinib in Cholangiocarcinoma beyond ALK Expression and Mutation

Cholangiocarcinoma (CCA) is a difficult-to-treat cancer, with limited therapeutic options and surgery being the only curative treatment. Standard chemotherapy involves gemcitabine-based therapies combined with cisplatin, oxaliplatin, capecitabine, or 5-FU with a dismal prognosis for most patients. R...

সম্পূর্ণ বিবরণ

গ্রন্থ-পঞ্জীর বিবরন
প্রধান লেখক: Kyaw Zwar Myint, Brinda Balasubramanian, Simran Venkatraman, Suchada Phimsen, Supisara Sripramote, Jeranan Jantra, Chaiwat Choeiphuk, Somkit Mingphruedhi, Paramin Muangkaew, Narongsak Rungsakulkij, Pongsatorn Tangtawee, Wikran Suragul, Watoo Vassanasiri Farquharson, Kanokpan Wongprasert, Somchai Chutipongtanate, Pimtip Sanvarinda, Marisa Ponpuak, Naravat Poungvarin, Tavan Janvilisri, Tuangporn Suthiphongchai, Kiren Yacqub-Usman, Anna M. Grabowska, David O. Bates, Rutaiwan Tohtong
বিন্যাস: প্রবন্ধ
ভাষা:English
প্রকাশিত: MDPI AG 2024-02-01
মালা:Pharmaceuticals
বিষয়গুলি:
cholangiocarcinoma
ceritinib
cancer
kinase inhibitors
antitumor agents
অনলাইন ব্যবহার করুন:https://www.mdpi.com/1424-8247/17/2/197

আন্তর্জাল

https://www.mdpi.com/1424-8247/17/2/197

অনুরূপ উপাদানগুলি